Why Access Profile Continues to Matter in Endovascular Hemorrhage Control and Postpartum Hemorrhage Management
In endovascular medicine, sheath size has always mattered. While advances in “slender” technology and vascular closure devices have improved the safety profile of larger systems, the fundamental reality remains unchanged: larger arterial access profiles increase the amount of vessel trauma created at the arteriotomy site.
For physicians managing hemorrhage, particularly postpartum hemorrhage (PPH), this question is especially important. Obstetric patients often present with small-caliber femoral arteries, physiologic vasoconstriction, and a hypercoagulable state; all factors that increase vulnerability to thrombosis and access-site complications.
As newer aortic occlusion technologies emerge, the question is no longer simply whether REBOA works. The question is whether lower-profile systems can deliver equivalent hemorrhage control while reducing access morbidity.
The evidence increasingly suggests that they can.
What the Data Shows About Sheath Size and Complications
The strongest modern comparative evidence for smaller transfemoral access comes from studies evaluating 4F versus 6F systems. In a prospective interventional radiology audit by Chung et al., overall post-procedure groin complications occurred in 1.8% of 4F cases compared with 11.2% of 6F cases. The difference was driven largely by reductions in hematoma formation and minor access-site complications.
The larger BIO4AMB multicenter trial evaluated 765 ambulatory peripheral interventions using 4F and 6F access strategies. Access-site complication rates remained low in both groups (2.8% vs 3.2%), while procedural success exceeded 99% in each arm. Importantly, the 6F cohort relied heavily on vascular closure devices, which likely reduced the apparent difference between access sizes.
Why Geometry Still Matters
The clinically important variable is not simply the French label itself, but the true outer diameter of the sheath crossing the artery.
Published data from the COBRA-OS first-in-human feasibility study demonstrated that the custom 4F sheath used with the device has an outer diameter of approximately 1.8 mm. By comparison, a representative standard 7F sheath may approach 3.1 mm outer diameter.
That difference may appear modest numerically, but the cross-sectional access area tells the real story:
• 4F sheath (1.8 mm OD): approximately 2.54 mm²
• Standard 7F sheath (3.1 mm OD): approximately 7.55 mm²
In practical terms, the 7F access profile creates roughly three times the arteriotomy area of the COBRA-OS 4F sheath.
Why This Matters in Postpartum Hemorrhage
Postpartum hemorrhage presents a uniquely high-risk vascular access environment. Patients are frequently hypotensive, vasoconstricted, and hypercoagulable. Femoral arteries are often small, particularly in younger women.
Current pelvic embolization techniques for PPH are already commonly performed using 4F or 5F access systems. Published uterine artery embolization series consistently report high technical success and low overall complication rates with these lower-profile approaches.
A large series of 251 PPH embolization cases demonstrated:
• Technical success: 89.6%
• Initial clinical success: 86.5%
• Overall hemorrhage control: 98%
By contrast, larger aortic balloon occlusion systems used in obstetric hemorrhage have demonstrated meaningful access-related complications. In one cohort of 278 patients treated with a 12F prophylactic REBOA strategy for placenta accreta spectrum, investigators reported:
• Arterial thrombosis: 2.88%
• IR-related complications: 7.19%
• Local hemorrhage and hematoma events
The authors specifically noted that smaller introducer sheaths may reduce access-related complications.
Conclusion
The evidence across peripheral intervention, REBOA, and postpartum hemorrhage management points in the same direction: downsizing matters.
Smaller femoral access profiles reduce arterial burden and may reduce complications without sacrificing procedural success. While modern 7F systems represented a major improvement over older 11–12F platforms, 4F access pushes that evolution even further.
In postpartum hemorrhage, where vascular access conditions are often hostile and every complication matters, the value of minimizing arterial injury becomes even more important.
The current evidence supports a clear conclusion: 4 French still matters.
And among emerging low-profile hemorrhage control technologies, COBRA-OS offers a compelling access-profile advantage that differentiates it from larger-diameter alternatives.
Selected References
1. Chung R, et al. Are complication rates lower with 4-Fr versus 6-Fr transfemoral arterial access? Cardiovasc Intervent Radiol. 2018.
2. Brodmann M, et al. Clinical outcomes of ambulatory endovascular treatment using 4F and 6F femoral access strategies: BIO4AMB Trial. Cardiovasc Intervent Radiol. 2021.
3. Büchler JR, et al. A randomized trial of 5 versus 7 French guiding catheters. Catheter Cardiovasc Interv. 2008.
4. DuBose JJ, et al. Comparison of 7F and 11–12F access for REBOA. J Endovasc Resusc Trauma Manag. 2019.
5. Power A, et al. Size matters: first-in-human study of a novel 4 French REBOA device. Trauma Surg Acute Care Open. 2021.
6. Gonsalves M, Belli AM. Arterial embolization for primary postpartum hemorrhage. J Vasc Interv Radiol. 2010.
7. Ye Y, et al. Efficacy of REBOA for hemorrhage control in abnormally invasive placenta. BMC Pregnancy Childbirth. 2023.
